Valye reports for unlimited access

Global Asset Management Group, Inc. operates as an asset management and real estate investment company with a focus on income-producing multifamily real estate and specialized industrial properties. The company has recently expanded its portfolio through acquisitions of industrial manufacturing facilities and infrastructure for health and wellness products, as well as options related to the cannabis industry. GAMG has established strategic financing arrangements to support disciplined capital deployment and growth. The company maintains governance and advisory structures to support its expansion and capital markets activities.

Archimedes Tech SPAC Partners II Co. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands with the primary objective of effecting a merger or business combination with a technology-focused target company. The company completed its initial public offering in February 2025, raising gross proceeds of $230 million, which are held in a trust account invested in U.S. government securities or money market funds. The company has not generated revenue or engaged in operations to date. Its management team brings significant experience in technology sectors and SPAC transactions, aiming to leverage their network and expertise to identify and complete a business combination within 21 months of the IPO. The company focuses on targets in artificial intelligence, cloud services, and automotive technology sectors, primarily in the U.S. but with potential international opportunities. The company maintains strong liquidity and reported net income in the first quarter of 2026, reflecting financial management of its trust assets and operations related to the SPAC structure.

Eline Entertainment Group, Inc. (EEGI) is a developmental stage company incorporated in 1997, formerly operating in food service and sports entertainment production but currently without active operations. Following abandonment of prior business activities and revocation of its charter, a court-appointed custodian reinstated the company in 2022 and appointed new management. Since then, EEGI has been seeking a merger, acquisition, reverse merger, or other business transaction with an operating company but has not finalized any agreements. The company has no revenue and reports ongoing losses, with minimal liquidity and limited management resources. It faces competition from various entities in identifying suitable acquisition targets and must comply with SEC reporting and governance requirements that impose additional costs. The company’s majority shareholder holds significant voting control, influencing corporate governance.

Horizon Space Acquisition II Corp. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in March 2023. Its business model is to identify and complete a business combination with one or more target companies, leveraging proceeds from its November 2024 IPO and private placements, which raised approximately $69 million held in a trust account. The company’s management team has extensive experience and networks in capital markets and public companies, aiming to create shareholder value through operational improvements and capital access in the target business. The company announced a definitive business combination agreement with SL Bio Ltd. in May 2025, involving a two-step merger process to form a new public company listed on Nasdaq. Shareholders approved the business combination and related proposals in February 2026. The company has extended the deadline to consummate the business combination multiple times, with extension fees deposited into the trust account and promissory notes issued. The company currently has no revenue and has incurred losses since inception, relying on proceeds from its IPO and loans from sponsors to fund operations. Its shares and rights trade on Nasdaq under symbols HSPT and HSPTR respectively.

DarkPulse, Inc. operates as a technology solutions provider specializing in integrated communications and security systems, as well as habitat management services. The company operates through subsidiaries located in the United States, United Kingdom, India, Turkey, and the United Arab Emirates. Its business model includes providing advanced technology services and products, with revenues primarily generated from service contracts recognized over time as milestones are achieved. The company’s manufacturing is outsourced to Sanmina Corporation. The company’s financials reflect ongoing net losses and significant liabilities exceeding current assets, highlighting liquidity constraints. It is actively pursuing additional capital through private placements and strategic partnerships to support its growth and operational needs [S2].

Omnitek Engineering Corp, founded in 2001 in California, specializes in technology to convert diesel engines to alternative fuels such as compressed natural gas, liquefied natural gas, renewable natural gas, hydrogen, and propane. The company provides conversion kits tailored for engines with or without turbochargers, new natural gas engines, and related components. Its patented technology uses a fuel-mixing device and electronic control unit to optimize fuel delivery and ignition timing. Omnitek's products serve a variety of markets including light commercial vehicles, buses, heavy-duty trucks, rail, marine, and stationary applications worldwide. The company distributes through a global network of dealers, system integrators, and fleet operators. Regulatory approvals from U.S. EPA, California Air Resources Board, and European Union support its product offerings. Omnitek's business model relies on converting existing diesel engines during scheduled overhauls, offering cost savings compared to purchasing new engines. The company faces competition from larger firms and must navigate complex regulatory environments and market dynamics influenced by fuel prices and environmental policies.

Citrine Global, Corp., operating as SkyTech Orion Global Corp., is focused on developing and manufacturing modular small drone systems designed for mass production and large-scale deployment, primarily targeting defense and dual-use markets. The company’s core technology is the SkyTech Replicator™ Modular Drone Platform, which features a proprietary modular architecture centered on a standardized Smart Core Unit™ that integrates control, power, communications, and payload management. This modular approach enables rapid reconfiguration and adaptation to diverse mission profiles, including intelligence, surveillance, reconnaissance, tactical operations, loitering munitions, and logistics support. The company’s manufacturing strategy, termed the Replication Manufacturing Method™, emphasizes scalable, distributed production cells with advanced technologies such as 3D printing to support efficient, high-volume output while maintaining quality and regulatory compliance. SkyTech Orion Global Corp. is also developing the SkyTech Center Israel™, a government-backed national hub for drone manufacturing and innovation, supported by grants and incentives. The company holds multiple patent applications covering its multi-domain modular unmanned systems technology. Financially, as of the quarter ending March 31, 2026, the company reported a net loss and low liquidity ratios, indicative of ongoing investment in its growth initiatives and infrastructure.

Mosaic ImmunoEngineering Inc. operates as a development-stage biotechnology company specializing in immunotherapies targeting cancer. The company’s business model centers on identifying, developing, and commercializing novel immunotherapy product candidates. It has a management team with scientific and regulatory expertise and pursues licensing and acquisition of new technologies to build its pipeline. The company has engaged in a reverse merger and has licensed and terminated agreements related to its CPMV platform technology. Manufacturing is outsourced to third-party organizations, with plans to develop internal capabilities as capital permits. Regulatory compliance with FDA and international authorities is a key aspect of its product development process. The company currently has no commercial products or sales capabilities and focuses on research and development activities. Financially, the company reports net losses and limited cash resources, with ongoing needs for capital to fund operations and development programs. It faces competition from larger pharmaceutical and biotech companies with more resources and established products.

Loan Artificial Intelligence Corp., formerly known as Vestiage, Inc., is a developmental stage company incorporated in Florida with a history of multiple business pivots. The company abandoned its previous nutraceutical business and is currently focused on mergers, acquisitions, and other financial transactions. It has not yet implemented its business plan or generated revenue. The company completed a reverse stock split and name change in 2025. It has identified a technology company in Hong Kong as a potential acquisition target and received audited financial statements for this target. The company has a small management team and faces competition from various entities in locating suitable merger candidates. It reports operating losses and liquidity constraints as of the latest quarter. The company is subject to U.S. securities regulations and is dependent on raising capital to fund acquisitions and operations.

VF Corporation operates globally in the apparel, footwear, equipment, and accessories market, marketing products under owned brands such as The North Face, Timberland, Vans, and others. The company realigned its segments in Fiscal 2026 into Outdoor and Active, with an additional 'All Other' category for smaller brands. Revenues for Fiscal 2026 were $9.6 billion, with the Outdoor segment growing 8% and the Active segment declining 7%. The company sells products through wholesale and direct-to-consumer channels across Americas, Europe, and Asia-Pacific. VF completed the divestiture of the Dickies brand in November 2025. The company reported improved profitability metrics including gross margin and operating margin, supported by cost savings initiatives and pricing strategies. VF maintains a strong liquidity position and continues to manage its portfolio with a focus on profitable growth and leverage reduction.

Kraig Biocraft Laboratories, Inc. develops and produces spider silk biomaterials by genetically engineering silkworms to spin spider silk fibers. The company is advancing its production scale through deployment of BAM-1 Alpha production hybrids and acquisition of rearing centers and mulberry fields to support large-scale operations. Its technology and production efforts have been recognized in scientific media such as National Geographic. Kraig Biocraft targets industrial, defense, and eco-luxury apparel markets with its spider silk products. The company operates as a smaller reporting company and provides limited financial disclosures in SEC filings.

HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on developing novel biologic therapies, including fusion proteins and T-cell engagers, targeting autoimmune diseases, alopecia areata, and solid tumors. The company is headquartered in Miramar, Florida, and trades on Nasdaq under the ticker HCWB. Its pipeline includes assets such as HCW9302 for alopecia areata, HCW11-006 under a licensing agreement, and HCW9206, a fusion protein designed to enhance CAR-T cell therapy. The company has reported recent net income and earnings per share for Q1 2026, despite historically low or no revenue. HCW Biologics has engaged in equity offerings and consulting agreements to support its operations and marketing efforts. It has also addressed Nasdaq listing compliance issues and regained compliance as of mid-2025.

Vine Hill Capital Investment Corp. II is a special purpose acquisition company (SPAC) formed as a Cayman Islands exempted company in August 2025. Its primary objective is to identify and complete an initial business combination with one or more target businesses, typically with an aggregate enterprise value of $500 million or more. The company completed its initial public offering in December 2025, raising $230 million, which is held in a trust account until used for a business combination or returned to shareholders if no combination occurs within 24 months. The company has not yet commenced operations or generated revenue. The management team and board have significant experience in SPAC transactions, mergers and acquisitions, and investment banking, which they intend to leverage to identify and acquire suitable targets. The company focuses on leveraging its network and operational expertise to create value post-combination.

GalaxyEdge Acquisition Corp is a Cayman Islands exempted company formed as a special purpose acquisition company (SPAC). It completed its initial public offering on March 5, 2026, issuing units consisting of ordinary shares and rights to additional shares upon consummation of a business combination. The IPO raised $100 million in gross proceeds, with an additional $15 million from the exercise of the over-allotment option and $2.2 million from a private placement. The proceeds were placed in a trust account for public shareholders. The company has entered into a definitive merger agreement with Rongcheng Group Limited and related entities to consummate a business combination through a merger structure. The merger contemplates share conversions and an agreed pre-money valuation of $350 million for the target company. Post-merger governance will include directors and officers designated by both parties. The company is classified as an emerging growth company and is not required to disclose certain risk factors due to its smaller reporting company status. Financial disclosures as of March 31, 2026, show net income of $157,011 and current liabilities of $379,317, with limited liquidity data available.

BTCS Inc. operates as an active participant in the Ethereum blockchain ecosystem, generating revenue through three complementary business lines: Validator Node Operations (NodeOps), Block Building (Builder+), and Decentralized Finance Operations (Imperium). NodeOps involves operating validator nodes that perform consensus and block finalization activities, earning ETH-denominated staking rewards. Builder+ focuses on constructing optimized transaction blocks for submission to validators, generating fees from successful block proposals while incurring validator payments as costs. Imperium, launched in 2025, deploys ETH and stablecoins into DeFi protocols to earn variable rewards based on protocol utilization and market conditions. The company strategically realigned in 2025 to focus solely on Ethereum, discontinuing non-Ethereum operations and legacy platforms. BTCS employs a capital strategy integrating decentralized finance borrowing and traditional equity offerings to fund growth and asset deployment. The company prioritizes secure self-custody of digital assets using cold and hot wallets and limits use of exchanges to transactional needs. BTCS operates in a competitive environment with a small team and aims to expand scalable, high-margin revenue opportunities within the Ethereum ecosystem.

CSLM Digital Asset Acquisition Corp III, Ltd is a special purpose acquisition company (SPAC) incorporated in July 2024 in the Cayman Islands. Its purpose is to identify and complete a business combination with one or more companies primarily in digital assets, Web3, financial services infrastructure, and blockchain-related sectors, with a focus on emerging and frontier markets. The company completed its IPO in August 2025, raising approximately $230 million, which is held in a trust account pending a business combination. It has not generated operating revenues and is currently seeking a target. The company announced a non-binding letter of intent with First Digital Group Ltd. in December 2025 for a potential business combination. The management team leverages extensive experience and networks in frontier markets and emphasizes ESG principles in its investment approach. The company’s shares and warrants trade on Nasdaq under KOYN and KOYNW, respectively.

PrimeEnergy Resources Corporation, established in 1973 and headquartered in Houston, Texas, is an independent oil and natural gas company operating primarily in Texas and Oklahoma. The company owns producing and non-producing properties, including a 12.5% overriding royalty interest in West Virginia and an idle offshore pipeline in Texas. It focuses on horizontal drilling targeting multiple pay intervals in the Midland Basin, with significant investments in recent years. The company derives revenue mainly from oil, natural gas, and NGL sales, selling production on the open market or through forward contracts. It maintains liquidity through operational cash flow, a revolving credit facility, and cash reserves. PrimeEnergy actively pursues acquisitions to expand its income-producing assets and leasehold acreage, aiming to balance current commodity price challenges with future development opportunities.

Sachem Capital Corp. operates as a real estate finance company organized as a REIT, focusing on originating and managing a portfolio of short-term loans secured by first mortgage liens on real estate. The company lends primarily to real estate investors and developers for property acquisition, renovation, and development. Its loans are typically secured by real estate and additional collateral such as ownership interests and personal guarantees. The company generates revenue from interest and fees related to its loan portfolio. It employs a conservative underwriting approach emphasizing loan-to-value ratios and thorough due diligence. The loan portfolio is diversified by loan size, property type, and geography, with primary markets in Connecticut, Florida, Massachusetts, and New York. Management has extensive experience in real estate finance and accounting. The company uses digital marketing, borrower retention, and strategic partnerships to drive loan originations. Financially, the company reported a net loss in Q1 2026 and maintains a significant debt level relative to capital. The competitive landscape includes banks, specialty finance companies, and other institutional lenders.

DUKE Robotics Corp. is a technology company specializing in advanced robotic stabilization systems and drone-based solutions. Its product portfolio includes a stabilized robotic system enabling precise remote firing of small arms and light weapons, primarily for military and homeland security applications, and a civilian drone system for cleaning high-voltage electric utility insulators. The company operates through its wholly owned subsidiaries in Israel and Greece, focusing on global commercialization with emphasis on Europe and the United States. DUKE Robotics collaborates with Elbit Systems for marketing and sales of its military drone systems and has developed AI-powered aerial monitoring solutions to complement its drone services. The company has recently completed a reverse stock split and uplisted to NASDAQ, supporting its capital raising and growth initiatives.

Starfighters Space, Inc. is a Delaware-incorporated commercial aerospace company headquartered at Cape Canaveral, Florida. It operates a unique fleet of seven Lockheed F-104 supersonic aircraft, offering services in pilot and astronaut training, launch services, in-flight testing, and hypersonic research. The company is developing air-launched rocket systems (StarLaunch I and II) to provide cost-effective, reusable launch capabilities for small payloads to suborbital and low earth orbit altitudes. Starfighters leverages its operational history, strategic location at Kennedy Space Center and Midland International Air & Space Port, and partnerships with government and industry players to serve defense, commercial, academic, and civil clients. The company completed its IPO in December 2025 and is listed on the NYSE American under ticker FJET.

Cavitation Technologies, Inc. designs and engineers environmentally friendly technology-based systems that serve large global markets including vegetable oil refining, renewable fuels, water treatment, algae oil extraction, biodiesel production, water-oil emulsions, and crude oil yield enhancement. The company has developed and patented proprietary Nano Reactor® technology, which is a key component of its Nano Neutralization® System, commercially proven to reduce operating costs and increase yields in processing oils and fats. The company manufactures Nano-Reactors for refining vegetable oils, biodiesel transesterification, and treatment of produced and frack water. It also develops low pressure non-reactors (LPN) for multiple industries and miniaturized non-reactors for consumer products such as enhanced spirits, wines, and infused drinking water. Cavitation Technologies operates in a single segment with a unified sales and operations structure. The company has significant customer concentration, with one customer accounting for all revenue in a recent period. Revenue recognition includes product sales, license fees, patent assignments, usage fees, and rental income. The company reported $3,000 in revenue and a net loss of $219,000 for the quarter ended March 31, 2026, with liquidity ratios indicating limited short-term financial flexibility. [S2]

Wenyuan Group Corp. is a holding company conducting substantially all of its business through its subsidiaries in China. The company reported revenue of approximately $24.6 million for the year ending December 31, 2025, and a net loss of about $63.7 million for the quarter ending March 31, 2026. Its liquidity position as of March 31, 2026, shows current assets significantly lower than current liabilities, with a current ratio of 0.21, indicating potential liquidity constraints. The company operates within the regulatory environment of the People's Republic of China, which involves complex and evolving laws, including foreign exchange controls and labor regulations. These factors, along with legal proceedings related to property and currency exchange risks, contribute to operational and financial uncertainties.

ModuLink Inc. is a holding company incorporated in Nevada, conducting business through subsidiaries primarily in Hong Kong, Australia, and the British Virgin Islands. Its core business is property development using modular integrated construction technology (MiC), enhanced by proprietary air-to-water (A2W) technology and IoT-enabled property management systems. The company aims to develop sustainable, smart, and energy-efficient communities across multiple continents. Its subsidiaries cover strategic planning, design and engineering, technology development, and project management. ModuLink completed the acquisition of a 60% stake in ASA Robotics Limited, a robotics and AI solutions company, in April 2026, integrating advanced automation technologies into its portfolio. The company finances operations through equity issuances, debt, and support from officers and directors, with noted liquidity challenges as of Q1 2026.

urban-gro, Inc. was founded in 2014 and transitioned from a Colorado-based design-build firm focused on Controlled Environment Agriculture (CEA) to a Delaware corporation trading on NASDAQ under the ticker UGRO. In 2026, the company completed a reverse merger with Flash Sports & Media, Inc., shifting its business focus to sports, media, and experiential marketing. The merger incorporated IPG's cricket commercialization business, including exclusive rights to the Lanka Premier League. Prior to the merger, urban-gro's revenue was derived from equipment systems sales, construction design-build contracts, and services, with the latter two segments discontinued or wound down in 2025. The company recognizes revenue based on transfer of control for equipment and over time for construction contracts, applying significant judgment in revenue recognition. Financially, the company has experienced recurring losses, a net capital deficiency, and liquidity constraints, with a current ratio of 0.05 as of March 31, 2026. The company has relied on dilutive financing and faces risks related to integration, seasonality, foreign currency exposure, and regulatory environments in Sri Lanka and the UAE.

MGSD operates through its subsidiary Tongzhilian, headquartered in Beijing, China, providing cultural tourism services including education and family tours, distributing Chinese cultural and creative products, and planning to expand into arts expositions. The company designs tours with cultural content, cooperates with third-party operators for logistics, and markets through a network of sales agents. Product sales include tea, alcohol, gift cards, and plans for proprietary cultural product lines targeting youth markets. Arts expositions involve participatory cultural presentations marketed similarly to tours. MGSD holds necessary operating licenses in Beijing and emphasizes multiple service and product offerings, leveraging the CEO's extensive marketing experience and social network. The company faces a highly competitive market with various cultural tourism and product providers. Seasonality affects tourism and exposition sales but not product sales. MGSD does not maintain insurance for property or liability risks. Financially, the company reported a net loss and limited revenue as of Q2 2026, with liquidity challenges indicated by a current ratio below 1. MGSD has engaged in strategic agreements to integrate educational technology and intangible cultural heritage resources into its offerings [S1][S2][S16][S18].

Alibaba Group Holding Ltd is a major player in the Internet Retail industry, operating primarily in the Consumer Cyclical sector. The company reported $148.4 billion in revenue and $15.0 billion in net income for the fiscal year ending March 31, 2026. Its liquidity position as of that date shows a current ratio of 1.28 and a cash ratio of 0.29, indicating moderate short-term financial flexibility. Alibaba's business model includes significant investments in technology, particularly in AI and cloud computing, which are key focus areas in recent public discourse. The company faces competitive pressures but maintains a strong market presence and ongoing innovation initiatives.

X3 Acquisition Corp. Ltd. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands. Its business purpose is to identify and complete an initial business combination with one or more target companies, primarily focusing on the financial services industry but remaining open to other sectors. The company completed its IPO in January 2026, issuing units consisting of Class A ordinary shares and redeemable warrants, raising gross proceeds of $225 million including over-allotment and private placement warrants. These proceeds are held in a trust account invested in low-risk instruments. The company has no operating history or revenue and is classified as a shell company. Its management team has extensive experience in financial services and capital markets. The company plans to conduct thorough due diligence on potential targets and aims to complete a business combination within 24 months of the IPO, subject to possible extension. If unsuccessful, it will redeem public shares and liquidate.

Capstone Holding Corp. is a publicly traded company on Nasdaq (ticker CAPS) operating primarily through its consolidated subsidiary TotalStone, LLC, which manufactures and sells stone products. The company maintains inventories valued at the lower of cost or net realizable value, with reserves for obsolete inventory. Its asset base includes property, equipment, goodwill, and intangible assets. The company has reported consistent net losses in recent years, with a negative equity position as of the end of 2024. Liquidity metrics as of Q1 2026 show current liabilities slightly exceeding current assets and minimal cash on hand. The company has outstanding debt including convertible notes, some of which have been converted into common stock, causing dilution. It also has related party management fee arrangements with Brookstone Partners IAC. The company faces regulatory risks related to Nasdaq listing standards and financial covenant compliance.

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to developing therapies for autoimmune diseases by targeting the neonatal fragment crystallizable receptor (FcRn) to reduce pathogenic IgG antibodies. Its lead product candidate, IMVT-1402, is designed to achieve deep IgG reductions with a favorable safety profile and convenient administration via a self-injector. The company is conducting multiple potentially registrational clinical trials across six autoimmune indications, including Graves' disease, difficult-to-treat rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, Sjögren's disease, and a proof-of-concept trial in cutaneous lupus erythematosus. Immunovant previously developed batoclimab, a first-generation FcRn inhibitor, but discontinued its development after Phase 3 thyroid eye disease trials failed to meet primary endpoints. The company relies on a license agreement with HanAll Biopharma for intellectual property rights and has significant cash reserves to fund ongoing clinical development. It has not generated revenue and continues to incur operating losses.

Analog Devices Inc is a semiconductor company operating globally with a diversified product portfolio serving Industrial, Automotive, Communications, and Consumer markets. The company sells through multiple channels including distributors and direct customers. Recent financial results show strong revenue growth driven by increased demand across all end markets, particularly in AI infrastructure and aerospace and defense. The company maintains solid profitability and liquidity, with ongoing strategic initiatives including a global repositioning program and acquisitions to enhance its AI capabilities.

Roivant Sciences Ltd. is a biopharmaceutical company incorporated in Bermuda with principal offices in London, New York, and Basel. It is publicly traded on Nasdaq under the ticker ROIV. The company focuses on developing innovative therapies, as evidenced by its clinical trial activities and patent portfolio. Roivant reported strong liquidity as of March 31, 2026, with over $4 billion in cash, cash equivalents, and short-term investments, and maintains an active share repurchase program. The company recently settled patent litigation with Moderna related to lipid nanoparticle technology used in vaccines, involving significant payments and licensing agreements. Roivant has reported net losses in recent periods, reflecting ongoing investment in development activities.

Haemonetics Corporation develops and markets medical technologies aimed at improving healthcare quality and efficiency. The company operates through three main segments: Plasma, Blood Center, and Hospital. The Plasma segment provides automated plasma collection devices, disposables, and software solutions to optimize plasma collection for pharmaceutical manufacturing. The Blood Center segment offers blood collection and processing devices for plasma, red cells, and platelets, focusing on donor safety and operational efficiency. The Hospital segment includes Interventional Technologies (vascular closure devices, sensor-guided technologies, esophageal protection) and Blood Management Technologies (hemostasis management, cell salvage, transfusion management) designed to improve patient outcomes and reduce hospital costs. Haemonetics sells products globally through direct sales and distributors, with a significant portion of revenue concentrated among top customers. The company invests in research and development to innovate and enhance its product portfolio and holds numerous patents and trademarks to protect its intellectual property [S1].

CAVA Group, Inc. is a Delaware corporation formed in 2015, operating a fast-casual Mediterranean restaurant chain with 439 restaurants across 28 states and Washington, D.C. as of December 28, 2025. The company offers chef-curated and customizable bowls and pitas, with a menu designed to accommodate a wide range of dietary preferences. CAVA centrally produces dips, spreads, and dressings for its restaurants and sells these products in grocery stores. The company aims to expand its footprint to over 1,000 restaurants in the U.S. by 2032, leveraging trends in authentic ethnic cuisine, health and wellness, and convenience. It employs approximately 13,480 team members and emphasizes a strong culture and talent development programs. CAVA uses a data-driven approach to site selection and flexible restaurant designs, including digital ordering and drive-thru options. The company has vertically integrated manufacturing and a directly sourced supply chain with over 50 trusted partners. Recent financial disclosures show solid liquidity and profitability metrics for Q1 2026. The company faces competition from various foodservice and retail channels and operational risks related to growth and supply chain management [S1][S2].

American Resources Corp (ARC) is a diversified natural resources company headquartered in Fishers, Indiana. It operates through subsidiaries including American Infrastructure Corporation (AIC), which manages six coal mining and processing operations in the Central Appalachian and Illinois coal basins, and Electrified Materials Corporation (EMC), focused on recovered metal and steel aggregation and sales. ARC also owns ReElement Technologies LLC, a company specializing in purification and monetization of critical and rare earth elements and end-of-life magnets and batteries. ARC's coal products include metallurgical coal for steelmaking, pulverized coal injections, and high-BTU, low sulfur bituminous coal for industrial uses. The company competes domestically and internationally in coal and critical minerals markets against companies such as MP Materials and Arch Resources. ARC reported a net income of $55.4 million for 2025 despite zero revenue reported, reflecting non-operational gains or accounting factors. The company maintains a strong liquidity position with a current ratio of 2.19 as of year-end 2025.

Cyber Enviro-Tech, Inc. (CETI) is a Wyoming-based water science technology company founded in 1986, specializing in remediation of contaminated industrial wastewater with an initial focus on the oil & gas industry. The company integrates advanced technologies such as cyber, aerospace, satellite, and AI telemetry into its water filtration and alternative energy systems. CETI's pilot project was an oil field in West Texas, which was spun off in 2025 to focus on water and soil remediation technologies. CETI also held a majority stake in CETI Axenic, a water remediation company for commercial laundry, which ceased operations at the end of 2025. The company currently has no employees but engages consultants and pursues partnerships to shorten sales cycles. CETI aims to address water contamination issues globally, with potential applications in the Middle East, meat packing industry, and municipalities. Financially, CETI reported no revenue and a net loss of $7.64 million for 2025, with liquidity ratios indicating limited short-term financial strength. The company has entered into an equity purchase agreement to raise up to $30 million in capital.

Newton Golf Company, Inc. develops and sells premium golf equipment, including technology-driven golf shafts and putters designed to enhance player performance. The company emphasizes domestic manufacturing and assembly to maintain quality and operational flexibility. Its Newton Motion™ shaft product line, including the Fast Motion driver shaft, is a key growth driver. The company distributes products through multiple channels, including direct-to-consumer e-commerce, professional club fitters, and retail partners, with a primary focus on the U.S. market and select international markets such as Japan and South Korea. Newton Golf invests in marketing and professional endorsements to build brand awareness and expand market penetration. The company has completed multiple public offerings and corporate restructuring events, including reverse stock splits, to support its growth strategy.